Recently, the Central Drugs Standard Control Organization (CDSCO) banned the importation of reconditioned or used medical equipment into India. Aiming to protect patient safety and encourage domestic production, this decision has sparked conflicting responses within the healthcare sector. The ramifications of this action are examined in more detail below.
Credits: Mint
Protecting the Domestic Industry
Protecting India’s developing medical device sector from the flood of inexpensive, used equipment is one of the main reasons for this prohibition. Approximately 60% of India’s 40,000 crore worth of imported medical equipment is currently thought to be refurbished. The government wants to level the playing field for domestic producers and ensure their growth and sustainability by limiting their imports.
The action was praised as a “true policy intervention” by Dr. Jitendra Sharma, the managing director of AMTZ in Visakhapatnam. He pointed out that this would guarantee improved medical care and stop the importation of old, dubious-quality equipment into the Indian market.
Ensuring Patient Safety
Patient safety is a key concern driving this prohibition. Refurbished devices often carry risks such as radiation emissions, unreliable test results, and outdated technology. Dr. Aakaar Kapoor, Founder-partner of City Imaging & Clinical Labs, highlighted that newer imaging systems are designed to emit significantly lower radiation, mitigating health risks during scans.
Moreover, the Medical Devices Rule, 2017, lacks specific provisions to regulate refurbished equipment. Without a proper licensing framework, these devices could compromise patient care standards.
The Argument for Affordable Healthcare
While the ban aims to improve safety and boost local manufacturing, it also raises concerns about affordability. Hospitals and diagnostic centers argue that refurbished devices have been instrumental in keeping healthcare costs low in India. By leveraging these lower-cost machines, many facilities have managed to provide imaging tests and other diagnostic services at prices significantly lower than in developed countries.
A Delhi hospital owner remarked, “Cost of imaging tests is lower in India compared to developed nations because of refurbished machines. Instead of banning them outright, the government should introduce regulations to ensure they meet safety and performance standards.”
Boost to Local Manufacturing
For med-tech companies, the prohibition is a welcome push towards self-reliance. India’s domestic medical device sector stands to benefit as hospitals and diagnostic centers shift towards purchasing new, locally manufactured equipment. This aligns with the government’s ‘Make in India’ initiative, aimed at reducing dependency on imports and fostering innovation within the country.
However, the industry must also address potential challenges, such as scaling up production capacity, ensuring cost competitiveness, and maintaining quality standards to meet the rising demand for advanced equipment.
Balancing Safety and Affordability
The ban has created a sharp divide between stakeholders. Proponents emphasize that patient safety and domestic manufacturing must take precedence. Critics, on the other hand, stress that an outright ban could drive up healthcare costs, making diagnostics less accessible for the average Indian.
A possible middle ground could involve introducing stringent regulations for refurbished devices. For instance, mandating certification to ensure safety and performance could address concerns without entirely eliminating the cost benefits these devices offer.
What Lies Ahead?
As the CDSCO enforces this ban, the healthcare industry faces a pivotal moment. While the move undeniably prioritizes patient safety and fosters domestic innovation, it also challenges hospitals and diagnostic centers to adapt to higher costs associated with new equipment.
The long-term success of this policy will depend on the government’s ability to support local manufacturers, provide subsidies or incentives, and establish a regulatory framework that balances safety with affordability. Ultimately, the goal must be to ensure that quality healthcare remains accessible to all Indians while promoting technological advancements in the medical device sector.
Credits: trak.in
Conclusion
The prohibition on refurbished medical devices is a bold step towards safeguarding patient care and bolstering domestic manufacturing. However, its impact on healthcare affordability and accessibility cannot be ignored. Striking the right balance between these priorities will be crucial as India navigates this transformative phase in its healthcare journey.
